Floatz logo

Enoxaparin

Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery

Medical University of Gdanskother_biologicalPhase 4 / ApprovedActive
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery cohort.

Asset / SponsorPhaseRating
WARFARIN
Northern Jiangsu People's Hospital
Phase 4A
Apixaban
Regeneron Pharmaceuticals
Phase 4BBB
Apixaban
Northern Jiangsu People's Hospital
Phase 4BBB
Acetylsalicylic Acid
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4BBB
NADROPARIN
Rijnstate Hospital
Phase 4BBB

View all 35 →

Same molecule, other indications

Enoxaparin is also rated in:

VTE (Venous Thromboembolism)Dormant
BBB
Indicative ·
78 / 100
View asset →
thrombophlebitisDormant
BBB
Indicative ·
74 / 100
View asset →
traumatic brain injuryDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →